Public health impact of adverse bone effects of oral corticosteroids

T.P. van Staa; L. Abenhaim; B Zhang; C. Cooper; H.G.M. Leufkens

Public health impact of adverse bone effects of oral corticosteroids

T.P. van Staa
, L. Abenhaim
, B Zhang
, C. Cooper
, H.G.M. Leufkens

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	601-607
Number of pages	7
Journal	British Journal of Clinical Pharmacology
Volume	51
Publication status	Published - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

Access to Document

Staa 01 publichealthimpactofadverseboneeffects
Open Access (free)
Final published version, 106 KB

Cite this

@article{78cf34d360084923bce95d290b39b255,

title = "Public health impact of adverse bone effects of oral corticosteroids",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "\{van Staa\}, T.P. and L. Abenhaim and B Zhang and C. Cooper and H.G.M. Leufkens",

year = "2001",

language = "Undefined/Unknown",

volume = "51",

pages = "601--607",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Public health impact of adverse bone effects of oral corticosteroids

AU - van Staa, T.P.

AU - Abenhaim, L.

AU - Zhang, B

AU - Cooper, C.

AU - Leufkens, H.G.M.

PY - 2001

Y1 - 2001

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Epidemiology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Ziekenhuisstructuur en organisatie van de gezondheidszorg

KW - Public Health

M3 - Article

SN - 0306-5251

VL - 51

SP - 601

EP - 607

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

ER -